Studies related to the PIK3CG gene were mainly focused on signal transduction of inflammation, and p110γ is a major driver of metabolic diseases, such as fatty liver disease and type-2 diabetes (Van Greevenbroek et al., 2013). This evidence concerns the gene PIK3CG and metabolic disease.